Physiomics is a leading oncology drug development consultancy using proprietary state of the artVirtual Tumour™ technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs ...

Biotechnology

Physiomics plc

Physiomics plc's headquarters in Oxford, United Kingdom

Jim Millen

Robert Jackson

Mark Middleton

The Leadership Team at Physiomics plc is responsible for setting the strategic direction and vision of the company, ensuring alignment with its mission to enhance oncology drug development. They oversee operational efficiency, drive innovation through the Virtual Tumour™ technology, and foster partnerships with pharmaceutical companies to accelerate cancer treatment advancements. This team plays a crucial role in guiding the organization's growth and ensuring the delivery of high-quality consultancy services.

Leadership Team

The Biosimulation Team at Physiomics plc leverages cutting-edge Virtual Tumour™ technology to model and simulate the efficacy and outcomes of oncology treatments. This team of expert scientists collaborates closely to analyze data and provide predictive insights, aiding the development and optimization of cancer therapies for our partners.

Physiomics plc

Org chart

Board & advisors

Teams

Leadership Team

Biosimulation Team

Offices

Physiomics plc

Org chart

Board & advisors

Teams

Leadership Team

Biosimulation Team

Offices

Related companies